45
Participants
Start Date
November 30, 2014
Primary Completion Date
July 31, 2016
Study Completion Date
July 31, 2016
Lenalidomide
Lenalidomide 25 mg by mouth for the first 21 days of a 28-day-cycle for 4 cycles
Adriamycin
Adriamycin as intravenous bolus infusion at a dose of 9 mg/m2, on days 1-4 of a 28-day cycle for 4 cycles
Dexamethasone
Dexamethasone by mouth at a dose of 40 mg, on days 1, 8, 15, and 22 of a 28-day cycle for 4 cycles
"General Hospital of Athens G. Gennimatas", Athens
"General Hospital of Athens Alexandra", Athens
University General Hospital of Patras, Pátrai
Theageneio Anticancer Hospital of Thessaloniki, Thessaloniki
Meletios A. Dimopoulos
OTHER